Stocks in Focus: Corning Inc. (NYSE:GLW), JinkoSolar Holding Co., Ltd. (NYSE:JKS), Alcoa Inc. (NYSE:AA), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Sabre Corporation (NASDAQ:SABR)

Corning Inc. (NYSE:GLW) said that, it is exiting its 72-year joint venture with The Dow Chemical Co., now known as Dow Corning, it will still have a stake in the Great Lakes Bay Region.

Corning Inc. (NYSE:GLW) belongs to Technology sector. Its net profit margin is 13.60% and weekly performance is 2.31%. On last trading day company shares ended up at $18.63. Corning Inc. (NYSE:GLW) distance from 50-day simple moving average (SMA50) is 4.32%.

JinkoSolar Holding Co., Ltd. (NYSE:JKS) noted that it would be adding 300MW of wafer capacity in the first quarter of 2016, followed by a further 200MW in the second quarter, taking nameplate in-house wafer capacity from 3GW at the end of 2015 to 3.5GW by the end of the first half of 2016.

On 01 March, JinkoSolar Holding Co., Ltd. (NYSE:JKS) shares moved up 1.17% and was closed at $24.18. JKS EPS growth in last 5 year was 51.20%. JinkoSolar Holding Co., Ltd. (NYSE:JKS) year to date (YTD) performance is -12.61%.

On 23 February, Alcoa Inc. (NYSE:AA) said that, Deere & Co., headquartered in Moline, and Alcoa, with its Alcoa Davenport Works facility in Riverdale, both were selected in the annual ranking on corporate reputation. Deere ranked 46th on the world’s Top 50 Most Admired Companies list. The top five companies on the 2016 Most Admired list were Apple, Alphabet, Amazon, Berkshire Hathaway and Walt Disney.

Alcoa Inc. (NYSE:AA) ended the last trading day at $9.11. Company weekly volatility is calculated as 4.27% and price to cash ratio as 6.24. Alcoa Inc. (NYSE:AA) showed a weekly performance of 6.80%.

On 25 February, Celldex Therapeutics, Inc. (NASDAQ:CLDX) reported business and financial highlights for the fourth quarter and year ended December 31, 2015. Cash, cash equivalents and marketable securities as of December 31, 2015 were $289.9 million compared to $304.6 million as of September 30, 2015.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares moved up 10.29% in last trading session and ended the day at $7.50. CLDX return on assets is -34.40%. Celldex Therapeutics, Inc. (NASDAQ:CLDX) quarterly performance is -57.96%.

On 25 February, Sabre Corporation (NASDAQ:SABR) announced the secondary public offering of 20,000,000 shares of common stock by existing stockholders affiliated with TPG Global, LLC and Silver Lake Management Company II, L.L.C. (the “Selling Stockholders”). All of the shares are being sold on a pro rata basis by the Selling Stockholders in accordance with their current interests, and the Selling Stockholders will receive all of the net proceeds from this offering. No shares are being sold by the Company.

Sabre Corporation (NASDAQ:SABR) shares advanced 3.13% in last trading session and ended the day at $28.00. SABR Gross Margin is 34.30% and its return on assets is 10.50%. Sabre Corporation (NASDAQ:SABR) quarterly performance is -5.37%.

Leave a Reply

Your email address will not be published. Required fields are marked *